GO
Loading...

Health Care Supplies

More

  • Hospitals See Surge of Weapons in War on 'Superbugs' Monday, 29 Apr 2013 | 8:24 AM ET

    The rise of "superbugs," and pressure from the government and insurers, is driving hospitals to try all sorts of new approaches to stop their spread.

  • J&J Tops Estimates on Newer Medicine Growth Tuesday, 16 Apr 2013 | 8:16 AM ET

    The pharmaceutical and medical devices company reported quarterly earnings and revenue Tuesday that exceeded Wall Street's expectations as growth of newer medicines for cancer, hepatitis C and blood clots offset declining sales of its treatments for heartburn and attention deficit disorder.

  • Roger Parloff, Fortune senior editor, says businesses are sprouting in states like Colorado and Washington, where selling cannabis is now legal.

  • Obamacare Wellness Programs Could Raise Health Costs Thursday, 21 Feb 2013 | 12:31 PM ET

    If you smoke, you might have to pay thousands extra for employee-based health insurance under Obamacare starting next year.

  • First on CNBC: Cochlear Earnings  Monday, 4 Feb 2013 | 9:35 PM ET

    On a First on CNBC interview, Cochlear CEO Chris Roberts tells CashFlow about his company's products and plans for global expansion.

  • J&J Knew About Widespread Hip Implant Failures: Audit Wednesday, 23 Jan 2013 | 9:52 AM ET

    An internal analysis conducted by Johnson & Johnson in 2011 estimated that the all-metal device would fail within five years in nearly 40 percent of patients who received it, newly disclosed court records show.

  • Pfizer Unit IPO Carries a Huge Price Tag Friday, 18 Jan 2013 | 8:17 AM ET

    Pfizer's unit Zoetis plans to sell 86.1 million shares at between $22 and $25 each in an initial public offering.

  • Major Flu Outbreak Could Slow US Economy Further Thursday, 10 Jan 2013 | 12:00 AM ET

    One of the worst flu seasons in a decade is putting further strains on an already sluggish U.S. economy as companies get slammed with increased health care costs and lower productivity from widespread worker absences.

  • Big Pharma Bets on Obesity Drug Binge Thursday, 27 Dec 2012 | 2:18 AM ET

    As Christmas overeating gives way to under-fulfilled new year diets, the pharmaceutical industry's appetite has been whetted for a fresh surge in business.

  • The managing partner of Google's venture capital, Bill Maris,  says under-investment in health sciences is short-sighted.

  • DNA

    The goal is to enable physicians and pharmaceutical companies to use complex genetic data to tailor treatment on an individual basis, according to Mike Pellini, CEO of Foundation Medical.

  • Fungal Meningitis Death Toll Reaches 8  Tuesday, 9 Oct 2012 | 1:22 PM ET

    According to the CDC, the death toll has now reached 8 from a contaminated steroid used to treat back pain that came from a Massachusetts Compounding pharmacy. The next update from the CDC will be at 2PM EST today.

  • Qualcomm's Jacobs: Mighty Payoff to Mobile Medicine Tuesday, 9 Oct 2012 | 10:53 AM ET

    Qualcomm's CEO Paul Jacobs says the smart phone will become a focal point for wirelessly connecting medical devices, diagnostics and sensors, and providing near real-time information.

  • Stakes for Alzheimer's Cure Rise as America Ages Monday, 8 Oct 2012 | 2:56 PM ET
    Man with Alzheimer

    The aging of America is taking a toll on the health care system. By 2050, the cost of treating Alzheimer's patients will hit $1 trillion a year.

  • Skin Cancer Thrives as Tanning Culture Survives Monday, 8 Oct 2012 | 8:17 AM ET
    Doctor examining skin cancer

    Despite piles of research on the skin cancer risks of sun exposure and tanning beds, dermatologists and cancer groups struggle to persuade people to protect their skin from ultraviolet rays.

  • Food Allergy Business Booms Monday, 8 Oct 2012 | 8:08 AM ET
    Strawberry Shortcakes

    With 12 million Americans allergic to one food item or another, sales of specialty foods are soaring.

  • A warning letter written by the Food & Drug Administration last week to ten companies that produce pre-workout supplements with the ingredient dimethylamyamine (DMAA) has sent shockwaves through the industry, not only to the producers of the products but to consumers who have taken them.

  • GNC Storefront

    The vitamin supplements industry is "one of the safest industries that exist," despite lack of Food and Drug Administration oversight of its products, GNC CEO Joseph Fortunato told CNBC Tuesday.

  • CEO Blog: Changing How We Pay for Healthcare Thursday, 27 Oct 2011 | 11:40 AM ET

    Is legislated healthcare reform here to stay? As we watch the presidential race heat up – and look to a Supreme Court ruling this summer — no one knows for sure. Regardless, we as a nation need to realize that traditional thinking around healthcare is forever changed.

  • Midlife Parents Face a Double Whammy Monday, 26 Sep 2011 | 9:41 AM ET

    While new midlife parents may bring a special appreciation and years of wisdom to their postponed families, age-related hurdles can hit bank accounts and snag retirement and estate planning, requiring difficult decisions.